Integration of gene signatures using biological knowledge
暂无分享,去创建一个
Michalis E. Blazadonakis | Michalis E. Zervakis | Dimitris Kafetzopoulos | M. Zervakis | D. Kafetzopoulos | M. Blazadonakis
[1] Teuvo Kohonen,et al. Self-Organizing Maps , 2010 .
[2] Feng Jiang,et al. Gene and pathway identification with Lp penalized Bayesian logistic regression , 2008, BMC Bioinformatics.
[3] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[4] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[5] A. Vazquez,et al. Integrating biological information into the statistical analysis and design of microarray experiments. , 2010, Animal : an international journal of animal bioscience.
[6] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[7] G. Parmigiani,et al. Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.
[8] R. Collins,et al. Polychemotherapy for early breast cancer: an overview of the randomised trials , 1998, The Lancet.
[9] Joshua M. Korn,et al. Comprehensive genomic characterization defines human glioblastoma genes and core pathways , 2008, Nature.
[10] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[11] Rabiya S Tuma. Multiple gene signatures aim to qualify risk in breast cancer. , 2005, Journal of the National Cancer Institute.
[12] Eytan Domany,et al. Outcome signature genes in breast cancer: is there a unique set? , 2004, Breast Cancer Research.
[13] M. Radmacher,et al. Pitfalls in the use of DNA microarray data for diagnostic and prognostic classification. , 2003, Journal of the National Cancer Institute.
[14] Yi Zhang,et al. Pathway analysis of gene signatures predicting metastasis of node-negative primary breast cancer , 2007, BMC Cancer.
[15] Stefan Michiels,et al. Prediction of cancer outcome with microarrays: a multiple random validation strategy , 2005, The Lancet.
[16] D. Slonim. From patterns to pathways: gene expression data analysis comes of age , 2002, Nature Genetics.
[17] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..
[18] Perry L. Miller,et al. Journal of Biomedical Informatics 40 (2007) 750–760 , 2006 .
[19] Stephen Cordner,et al. melbourne Aboriginal people trade land claim for dialysis , 1998, The Lancet.
[20] D. Rubin,et al. Statistical Analysis with Missing Data. , 1989 .
[21] Satoru Kuhara,et al. Recursive gene selection based on maximum margin criterion: a comparison with SVM-RFE , 2006, BMC Bioinformatics.
[22] J. Mesirov,et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. , 1999, Science.
[23] R Simon,et al. Diagnostic and prognostic prediction using gene expression profiles in high-dimensional microarray data , 2003, British Journal of Cancer.
[24] Michalis E. Blazadonakis,et al. The linear neuron as marker selector and clinical predictor in cancer gene analysis , 2008, Comput. Methods Programs Biomed..
[25] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.